High Tower Advisors, LLC Bristol Myers Squibb CO Put Options Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $9,696 - $11,570	200 New	200 $10,000
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $4.06 Million - $4.68 Million	67,800 Added 16950.0%	68,200 $375,000
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $293,706 - $320,215	-4,900 Reduced 92.45%	400 $0
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $4.29 Million - $4.95 Million	-77,700 Reduced 93.61%	5,300 $0
Q2 2017 Aug 14, 2017	BUY	N/A	83,000	83,000 $108,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.